Press release (regulatory)
Skanska has signed a contract with Juno Therapeutics, Inc. to complete a tenant improvement at the company’s new South Lake Union headquarters in Seattle, USA. The contract is worth USD 43M, about SEK 360M, which will be included in the order bookings for Skanska USA Building for the third quarter 2016.
The project comprises of seven floors, about 14,000 square meters, at the Juno Therapeutics headquarters at 400 Dexter Ave. North in Seattle.
Construction is under way with completion scheduled for June 2017.
Skanska USA is one of the leading development and construction companies in the country, consisting of four business units: Skanska USA Building, which specializes in building construction; Skanska USA Civil, specialized in civil infrastructure; Skanska Infrastructure Development, which develops public-private partnerships; and Skanska USA Commercial Development, which develops commercial projects in select U.S. markets. Headquartered in New York, Skanska USA has more than 10,000 employees and its 2015 revenues were SEK 54.5 billion.
For further information, please contact:
Jay Weisberger, Communications, Skanska USA, tel: +1 206 494 54 69
Andreas Joons, Press Officer, Skanska AB, tel +46 (0)10 449 04 94
Direct line for media, tel +46 (0)10 448 88 99
This and previous releases can also be found atwww.skanska.com
Are you a journalist looking for information about Skanska or have questions about our operations? Our Media Relations team can help with press inquiries, interviews, background information and access to relevant resources.

Jacob Birkeland
Head of Media Relations & Public Affairs

Andreas Joons
Media Relations Manager

Olof Rundgren
Media Relations Manager